Stay updated on Cenobamate Open-Label Extension Study Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.

Latest updates to the Cenobamate Open-Label Extension Study Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedUpdate note shows a backend revision from v3.4.1 to v3.4.2; no changes to study details, eligibility, or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was implemented, replacing v3.4.0 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedStudy Record Dates now display 'Last Update Posted' instead of 'Last Update Posted (Estimated)'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded an estimated 'Last Update Posted' timestamp and updated the page to Revision: v3.3.4. Removed the older 'Last Update Posted' label and Revision: v3.3.3.SummaryDifference0.1%

- Check48 days agoChange DetectedNew Bulgarian study sites were added in Blagoevgrad (2700), Sofia (1407 and 1408), Varna (9000), and Veliko Tarnovo (5000 and 5100). Some previously listed locations in Sofia, Varna, Veliko Tarnovo, and Blagoevgrad were removed.SummaryDifference0.8%

- Check69 days agoChange DetectedAdded an expanded list of study locations across multiple US states and international regions (including California, Florida, Hawaii, Idaho, Maine, Maryland, Minnesota, Missouri, New Jersey, New York, North Carolina, Pennsylvania, Washington, as well as Blagoevgrad, Sofia, Varna, Veliko Tarnovo, and several Polish and Ukrainian regions), and updated the record revision to v3.3.3.SummaryDifference2%

Stay in the know with updates to Cenobamate Open-Label Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.